<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1814-6023-2023-20-3-243-255</article-id><article-id custom-type="elpub" pub-id-type="custom">vestim-928</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Влияние ионизирующего излучения (лучевой терапии) на структурно-функциональное состояние сывороточного альбумина у больных раком шейки матки</article-title><trans-title-group xml:lang="en"><trans-title>Effect of ionizing radiation (radiation therapy) on the structural and functional state of serum albumin with cervical cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1518-7715</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пузан</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Puzan</surname><given-names>N. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пузан Наталья Дмитриевна – научный сотрудник.</p><p>ул. Федюнинского, 4, 246007, Гомель</p></bio><bio xml:lang="en"><p>Natallia D. Puzan – Researcher, Institute of Radiobiology of the National Academy of Sciences of Belarus.</p><p>4, Fedyuninskу Str., 246007, Gomel</p></bio><email xlink:type="simple">natali_lu@tut.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беляковский</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyakovskiy</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беляковский Василий Николаевич – доктор медицинских наук, профессор.</p><p>ул. Ланге, 5, 246000, Гомель</p></bio><bio xml:lang="en"><p>Vasiliy N. Belyakovskiy – D. Sc. (Med.), Professor, Gomel State Medical University.</p><p>5, Lange Str., 246000, Gomel</p></bio><email xlink:type="simple">vnbel55@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чешик</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Cheshik</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чешик Игорь Анатольевич – кандидат медицинских наук, доцент, директор.</p><p>ул. Федюнинского, 4, 246007, Гомель</p></bio><bio xml:lang="en"><p>Igor A. Cheshik – Ph. D. (Med.), Associate Professor, Director, Institute of Radiobiology of the National Academy of Sciences of Belarus.</p><p>4, Fedyuninskу Str., 246007, Gomel</p></bio><email xlink:type="simple">igor.cheshik@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлов</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mihailov</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михайлов Игорь Викторович – кандидат медицинских наук, доцент, заведующий кафедрой.</p><p>ул. Ланге, 5, 246000, Гомель</p></bio><bio xml:lang="en"><p>Igor V. Mihailov – Ph. D. (Med.), Associate Professor, Head of the Department, Gomel State Medical University.</p><p>5, Lange Str., 246000, Gomel</p></bio><email xlink:type="simple">igor-mikhailov-2014@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт радиобиологии НАН Беларуси</institution></aff><aff xml:lang="en"><institution>Institute of Radiobiology of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>02</day><month>09</month><year>2023</year></pub-date><volume>20</volume><issue>3</issue><fpage>243</fpage><lpage>255</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пузан Н.Д., Беляковский В.Н., Чешик И.А., Михайлов И.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Пузан Н.Д., Беляковский В.Н., Чешик И.А., Михайлов И.В.</copyright-holder><copyright-holder xml:lang="en">Puzan N.D., Belyakovskiy V.N., Cheshik I.A., Mihailov I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/928">https://vestimed.belnauka.by/jour/article/view/928</self-uri><abstract><p>Флуоресцентным методом исследования установлено, что общая концентрация альбумина находится в пределах нормальных значений как для здоровых, так и для онкобольных на протяжении всего курса лучевой терапии. Анализ показателей, характеризующих структурно-функциональное состояние сывороточного альбумина (эффективная концентрация альбумина, резерв связывания альбумина и индекс токсичности) у больных раком шейки матки, показал, что количество полноценно функционирующего белка статистически достоверно снижается при сравнении с таковым в группе здоровых людей.</p><p>При изучении влияния лучевой терапии на структурно-функциональное состояние сывороточного альбумина онкобольных определено следующее: в 57 % случаев значения показателя индекса токсичности, характеризующего заполнение альбуминовых центров токсичными лигандами, увеличиваются после курса лучевой терапии, а в 43 % − уменьшаются; после 1-го сеанса лучевой терапии определяется дальнейшая динамика показателя индекса токсичности после лечения; возможно, место проживания пациента является определяющим фактором при развитии индивидуальной реакции транспортной системы сывороточного альбумина на действие терапевтических доз ионизирующего излучения.</p><p>Определение альбуминовых показателей, характеризующих структурно-функциональное состояние сывороточного альбумина, в частности индекса токсичности, у больных раком шейки матки, следует использовать в качестве индивидуального диагностического и прогностического критерия в динамике наблюдения за пациентами, проходящими лучевую терапию.</p></abstract><trans-abstract xml:lang="en"><p>The study of the literature on the detoxification properties of an albumin molecule and a prognostic value of determining albumin indicators allows us to conclude that it is undoubtedly important to assess the structural and functional properties of albumin in cancer patients at all stages of the diagnostic and treatment process already at the present time. At the same time, the lack of information makes it necessary and promising to widely introduce the fluorescent method for assessing total and effective albumin concentrations in the clinical and scientific work of oncologists.</p><p>Therefore, the aim of our work was to study the effect of radiation therapy on the structural and functional state of serum albumin in patients with cervical cancer.</p><p>In order to study radiation-induced changes in serum albumin when irradiated with therapeutic doses of ionizing radiation, the biological material (blood) of 28 people from the Gomel region was used: 1st group (control) – 13 healthy people; 2nd group – 15 patients diagnosed with cervical cancer who underwent remote gamma therapy (30 Gy). The collection of biological material in the 2nd group was carried out as follows: upon admission to patient treatment; after the 1st session of radiotherapy (2 Gy); after the 3rd session of radiotherapy (6 Gy); after the 5th session of radiotherapy (10 Gy); after the 7th session of radiotherapy (14 Gy); after the 10th session of radiotherapy (20 Gy), and after the 15th session of radiotherapy (30 Gy).</p><p>According to A. Gryzunov, G. E. Dobretsov’s method, the following indicators were determined: total albumin concentration (TAC) − the number of albumin molecules capable of binding toxic ligands is equal to the albumin concentration determined in any other way; effective albumin concentration (EAC) − the number of albumin binding centers is unoccupied by toxic ligands; the reserve of albumin binding (RAB) − it reflects the degree of structural modification of the protein; the index of toxicity (IT) − it characterizes the filling of albumin centers with toxic ligands.</p><p>The total albumin concentration is within normal values, both for healthy and cancer patients throughout the course of radiation therapy. The analysis of the indicators characterizing the structural and functional state of serum albumin (EAC, RAB, and IT) in patients with cervical cancer showed that the amount of fully functioning protein statistically significantly decreases when compared with a group of healthy people.</p><p>When studying the effect of radiation therapy on the structural and functional state of serum albumin in cancer patients, the following was determined: in 57 % of cases, the values of the IT indicator increase after a course of radiotherapy, and in 43 % − decrease;</p><p>after the 1st session of radiotherapy, further dynamics of IT after treatment is determined: if after 2 Gy the values of the IT indicator increase, then by the end of therapy this indicator will be higher than that when entering treatment, and, conversely, if after 2 Gy the values of the IT indicator decrease, then after the course of radiotherapy this indicator will be less than that when entering treatment;</p><p>it is possible that the patient’s place of residence is a determining factor in the development of an individual reaction of the serum albumin transport system to the effect of therapeutic doses of ionizing radiation.</p><p>The determination of albumin indicators characterizing the structural and functional state of serum albumin, in particular, the index of toxicity in patients with cervical cancer should be used as an individual diagnostic and prognostic criterion in the dynamics of observation of patients undergoing radiation therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>общая концентрация альбумина</kwd><kwd>эффективная концентрация альбумина</kwd><kwd>резерв связывания альбумина</kwd><kwd>индекс токсичности</kwd><kwd>лучевая терапия</kwd><kwd>рак шейки матки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>total albumin concentration</kwd><kwd>effective albumin concentration</kwd><kwd>reserve of albumin binding</kwd><kwd>index of toxicity</kwd><kwd>radiation therapy</kwd><kwd>cervical cancer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cervical cancer patient-derived orthotopic xenograft (PDOX) is sensitive to cisplatinum and resistant to nab-paclitaxel / T. Murakami [et al.]. // Anticancer Res. – 2017. – Vol. 37, N 1. – P. 61–65. https://doi.org/10.21873/anticanres.11289</mixed-citation><mixed-citation xml:lang="en">Murakami T., Murata T., Kawaguchi K., Kiyuna T., Igarashi K., Hwang H. K. [et al.]. Cervical cancer patient-derived orthotopic xenograft (PDOX) is sensitive to cisplatinum and resistant to nab-paclitaxel. Anticancer Research, 2017, vol. 37, no. 1, pp. 61–65. https://doi.org/10.21873/anticanres.11289</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nomogram predicting overall survival in operable cervical cancer patients / R.-R. Zheng [et al.] // Int. J. Gynecol. Cancer. – 2017. – Vol. 27, N 5. – P. 987–993. https://doi.org/10.1097/IGC.0000000000000987</mixed-citation><mixed-citation xml:lang="en">Zheng R.-R., Huang X.-W., Liu W.-Y., Lin R.-R., Zheng F.-Y., Lin F. Nomogram predicting overall survival in operable cervical cancer patients. International Journal of Gynecological Cancer, 2017, vol. 27, no. 5, pp. 987–993. https://doi.org/10.1097/IGC.0000000000000987</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model / K. Miyake [et al.]. // Arch. Gynecol. Obstet. – 2019. – Vol. 229, N 6. – P. 1683–1690. https://doi.org/10.1007/s00404-019-05147-3</mixed-citation><mixed-citation xml:lang="en">Miyake K., Murata T., Murakami T., Zhao M., Kiyuna T., Kawaguchi K. [et al.]. Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model. Archives of Gynecology and Obstetrics, 2019, vol. 229, no. 6, pp. 1683–1690. https://doi.org/10.1007/s00404-019-05147-3</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells / H. Chen [et al.] // Artific. Cells, Nanomed. Biotechnol. – 2021. – Vol. 49, N 1. – P. 240–249. https://doi.org/10.1080/21691401.2021.1890101</mixed-citation><mixed-citation xml:lang="en">Chen H., Feng X., Gao L., Mickymaray S., Paramasivam A., Alfaiz F. A., Almasmoum H. A., Ghaith M. M., Almaimani R. A., Ibrahim I. A. A. Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells. Artificial Cells, Nanomedicine, and Biotechnology, 2021, vol. 49, no. 1, pp. 240–249. https://doi.org/10.1080/21691401.2021.1890101</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: a systemic review, meta-analysis, and meta-regression of observational studies / X. Han [et al.] // Gynecol. Oncol. – 2021. – Vol. 160, N 1. – P. 351–360. https://doi.org/10.1016/j.ygyno.2020.10.011</mixed-citation><mixed-citation xml:lang="en">Han X., Liu S., Yang G., Hosseinifard H., Imani S., Yang L., Maghsoudloo M., Fu S., Wen Q., Liu Q. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: a systemic review, meta-analysis, and meta-regression of observational studies. Gynecologic Oncology, 2021, vol. 160, no. 1, pp. 351–360. https://doi.org/10.1016/j.ygyno.2020.10.011</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy / Y. Xiao [et al.] // Int. J. Clin. Exp. Pathol. – 2015. – Vol. 8, N 5. – P. 5273–5281.</mixed-citation><mixed-citation xml:lang="en">Xiao Y., Ren Y.-K., Cheng H.-J., Wang L., Luo S.-X. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy. International Journal of Clinical and Experimental Pathology, 2015, vol. 8, no. 5, pp. 5273–5281.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wang, J. Identification and validation of potential mRNA-microRNA-long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer / J. Wang, C. Zhang // Bioengineered. – 2021. – Vol. 12, N 1. – P. 898–913. https://doi.org/10.1080/21655979.2021.1890377</mixed-citation><mixed-citation xml:lang="en">Wang J., Zhang C. Identification and validation of potential mRNA-microRNA-long-noncoding RNA (mRNA-miR-NA-lncRNA) prognostic signature for cervical cancer. Bioengineered, 2021, vol. 12, no. 1, pp. 898–913. https://doi.org/10.1080/21655979.2021.1890377</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ермакова, Н. А. Роль химиотерапии на различных этапах лечения рака шейки матки / Н. А. Ермакова // Практ. онкология. – 2002. – Т. 3, № 3. – С. 211–219.</mixed-citation><mixed-citation xml:lang="en">Ermakova N. А. The role of chemotherapy at various stages of cervical cancer treatment. Prakticheskaya onkologiya [Practical oncology], 2002, vol. 3, no. 3, pp. 211–219 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy / M. Sanchez [et al.] // J. Hum. Nutr. Diet. – 2019. – Vol. 32, N 4. – P. 480–491. https://doi.org/10.1111/jhn.12649</mixed-citation><mixed-citation xml:lang="en">Sánchez M., Castro-Eguiluz D., Luvián-Morales J., Jiménez-Lima R., Aguilar-Ponce J. L., Isla-Ortiz D., Cetina L. Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy. Journal of Human Nutrition and Dietetics, 2019, vol. 32, no. 4, pp. 480–491. https://doi.org/10.1111/jhn.12649</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways / H. Liu [et al.] // Bioengineered. – 2021. – Vol. 12, N 1. – P. 565–577. https://doi.org/10.1080/21655979.2021.1880732</mixed-citation><mixed-citation xml:lang="en">Liu H., Song M., Sun X., Zhang X., Miao H., Wang Y. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways. Bioengineered, 2021, vol. 12, no. 1, pp. 565–577. https://doi.org/10.1080/21655979.2021.1880732</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Uracil-5-yl O-sulfamate: an illusive radiosensitizer. Pitfalls in modeling the radiosensitizing derivatives of nucleobases / P. Spisz [et al.] // J. Phys. Chem. B. – 2020. – Vol. 124, N 27. – P. 5600–5613. https://doi.org/10.1021/acs.jpcb.0c03844</mixed-citation><mixed-citation xml:lang="en">Spisz P., Zdrowowicz M., Kozak W., Chomicz-Mańka L., Falkiewicz K., Makurat S. [et al.]. Uracil-5-yl O-sulfamate: an illusive radiosensitizer. Pitfalls in modeling the radiosensitizing derivatives of nucleobases. Journal of Physical Chemistry B, 2020, vol. 124, no. 27, pp. 5600–5613. https://doi.org/10.1021/acs.jpcb.0c03844</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Musywel, H. A. Effect of gold nanoparticles on radiation doses in tumor treatment: a Monte Carlo study / H. A. Al-Musywel, A. Laref // J. Lasers Med. Sci. – 2017. – Vol. 32, N 9. – P. 2073–2080. https://doi.org/10.1007/s10103-017-2329-0</mixed-citation><mixed-citation xml:lang="en">Al-Musywel H. A., Laref A. Effect of gold nanoparticles on radiation doses in tumor treatment: a Monte Carlo study. Journal of Lasers in Medical Science, 2017, vol. 32, no. 9, pp. 2073–2080. https://doi.org/10.1007/s10103-017-2329-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Powathil, G. G. Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model / G. G. Powathil, D. J. A. Adamson, M. A. J. Chaplain // PLOS Comp. Biol. – 2013. – Vol. 9, N 7. – P. e1003120. https://doi.org/10.1371/journal.pcbi.1003120</mixed-citation><mixed-citation xml:lang="en">Powathil G. G., Adamson D. J. A., Chaplain M. A. J. Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model. PLOS Computational Biology, 2013, vol. 9, no. 7, p. e1003120. https://doi.org/10.1371/journal.pcbi.1003120</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistance / Y. Huang [et al.] // ACS Appl. Mater. Interfaces. – 2014. – Vol. 6, N 21. – P. 19217–19228. https://doi.org/10.1021/am505246w</mixed-citation><mixed-citation xml:lang="en">Huang Y., Luo Y., Zheng W., Chen T. Rational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistance. ACS Applied Materials and Interfaces, 2014, vol. 6, no. 21, pp. 19217–19228. https://doi.org/10.1021/am505246w</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Артемова, Н. А. Нетрадиционные режимы фракционирования дозы как модификатор лучевой терапии у больных раком легкого / Н. А. Артемова // Здравоохранение. – 2008. – № 1. – С. 24–29.</mixed-citation><mixed-citation xml:lang="en">Artemova N. А. Unconventional dose fractionation regimens as a modifier of radiation therapy in patients with lung cancer. Zdravookhranenie [Healthcare], 2008, no. 1, pp. 24–29 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chemical and biological basis for development of novel radioprotective drugs for cancer therapy / R. Checker [et al.] // Free Rad. Res. – 2021. – Vol. 55, N 5. – P. 595–625. https://doi.org/10.1080/10715762.2021.1876854</mixed-citation><mixed-citation xml:lang="en">Checker R., Patwardhan R. S., Jayakumar S., Maurya D. K., Bandekar M., Sharma D., Sandur S. K. Chemical and biological basis for development of novel radioprotective drugs for cancer therapy. Free Radical Research, 2021, vol. 55, no. 5, pp. 595–625. https://doi.org/10.1080/10715762.2021.1876854</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Patient radiation exposure: imaging during radiation oncology procedures: executive summary of NCRP Report No. 184 / M. T. Milano [et al.] // J. Am. Coll. Radiol. – 2020. – Vol. 17, N 9. – P. 1176–1182. https://doi.org/10.1016/j.jacr.2020.02.002</mixed-citation><mixed-citation xml:lang="en">Milano M. T., Mahesh M., Mettler F. A., Elee J., Vetter R. J. Patient radiation exposure: imaging during radiation oncology procedures: executive summary of NCRP Report No. 184. Journal of the American College of Radiology, 2020, vol. 17, no. 9, pp. 1176–1182. https://doi.org/10.1016/j.jacr.2020.02.002</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Альбумин сыворотки крови в клинической медицине : сб. ст. / под ред. Ю. А. Грызунова, Г. Е. Добрецова. – М. : Ириус, 1994. – 226 с.</mixed-citation><mixed-citation xml:lang="en">Gryzunov Yu. A., Dobretsov G. E. (eds.). Serum albumin in clinical medicine: a collection of articles. Moscow, Irius Publ., 1994. 226 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">The influence of oxidative stress on serum albumin structure as a carrier of selected diazaphenothiazine with potential anticancer activity / M. Maciazek-Jurzyk [et al.] // Pharmaceuticals. – 2021. – Vol. 14, N 3. – P. 285. https://doi.org/10.3390/ph14030285.</mixed-citation><mixed-citation xml:lang="en">Maciążek-Jurczyk M., Morak-Młodawska B., Jeleń M., Kopeć W., Szkudlarek A., Owczarzy A., Kulig K., Rogóż W., Pożycka J. The influence of oxidative stress on serum albumin structure as a carrier of selected diazaphenothiazine with potential anticancer activity. Pharmaceuticals, 2021, vol. 14, no. 3, p. 285. https://doi.org/10.3390/ph14030285</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma? / H. Y. Ellidag [et al.]. // Gut and Liver. – 2013. – Vol. 7, N 6. – P. 675–680. https://doi.org/10.5009/gnl.2013.7.6.675</mixed-citation><mixed-citation xml:lang="en">Ellidag H. Y., Bulbuller N., Eren E., Abusoglu S., Akgol E., Cetiner M., Yılmaz N. Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma? Gut and Liver, 2013, vol. 7, no. 6, pp. 675–680. https://doi.org/10.5009/gnl.2013.7.6.675</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Systemic inflammatory score predicts overall survival in patients with cervical cancer / M. Xu [et al.]. // J. Cancer. – 2021. – Vol. 12, N 12. – P. 3671–3677. https://doi.org/10.7150/jca.56170</mixed-citation><mixed-citation xml:lang="en">Xu M., Wu Q., Cai L., Sun X., Xie X., Sun P. Systemic inflammatory score predicts overall survival in patients with cervical cancer. Journal of Cancer, 2021, vol. 12, no. 12, pp. 3671–3677. https://doi.org/10.7150/jca.56170</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Афанасьева, А. Н. Клиническое значение определения альбуминовых показателей у онкологических больных / А. Н. Афанасьева, В. А. Евтушенко // Анестезиология и реаниматология. – 2004. – № 6. – С. 64–68.</mixed-citation><mixed-citation xml:lang="en">Afanas’eva A. N., Evtushenko V. A. Clinical value of determination of albumin values in cancer patients. Anesteziologiya i reanimatologiya [Anesthesiology and intensive care], 2004, no. 6, pp. 64–68 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Нямаа, Д. Влияние среды на функциональные и структурные свойства сывороточных альбуминов. II. Влияние температуры на N-форму сывороточного альбумина человека / Д. Нямаа, О. Бат-Эрдэнэ, Э. А. Бурштейн // Молекуляр. биология. – 1984. – Т. 18, вып. 4. – С. 972–977.</mixed-citation><mixed-citation xml:lang="en">Nyamaa D., Bat-Erdene O., Burstein E. A. The influence of the medium on the functional and structural properties of serum albumins. II. The effect of temperature on the N-form of human serum albumin. Molekulyarnaya biologiya [Molecular biology], 1984, vol. 18, no. 4, pp. 972–977 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Афанасьева, А. Н. Влияние интраоперационной лучевой терапии на альбуминовые показатели крови больных раком желудка / А. Н. Афанасьева, В. А. Евтушенко // Рос. онколог. журн. – 2006. – № 2. – С. 41–44.</mixed-citation><mixed-citation xml:lang="en">Afanas’eva A. N., Evtushenko V. A. The effect of intraoperative radiotherapy on albumin blood count in patients with gastric cancer. Rossiiskii onkologicheskii zhurnal [Russian journal of oncology], 2006, no. 2, pp. 41–44 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Дозы облучения населения Гомельской области от основных источников радиационного воздействия, в том числе медицинской рентгенодиагностики / Н. Г. Власова [и др.]. // Проблемы здоровья и экологии. – 2006. – № 3 (9). – С. 7–18.</mixed-citation><mixed-citation xml:lang="en">Vlasova N. G., Kuznetsov B. K., Visenberg Yu. V., Leshcheva S. V., Eventova L. N., Matskevich S. A., Kalinin D. I. Doses in Gomel population due to main sources of radiation, including chernobyl and medicine radiology. Problemy zdorov’ya i ekologii = Health and environmental issues, 2006, no. 3 (9), pp. 7–18 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Клиническое значение определения состояния центров связывания сывороточного альбумина при беременности / Н. Д. Луковская [и др.]. // Вес. Нац. акад. навук Беларусі. Сер. мед. навук. – 2008. – № 3. – С. 58–63.</mixed-citation><mixed-citation xml:lang="en">Lukovskaya N. D., Gromyko N. L., Baranovskaya E. I., Malenchenko A. F. Clinical significance of determining the state of serum albumin binding centers during pregnancy. Vestsi Natsyyanal’nai akademii navuk Belarusi. Serуya medуtsynskikh navuk = Proceedings of the National Academy of Sciences of Belarus. Medical series, 2008, no. 3, pp. 58–63 (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
